Testosterone and the heart: friend or foe?
Susan R DavisPublished in: Climacteric : the journal of the International Menopause Society (2023)
Cardiovascular disease (CVD) is the leading cause of death in women aged 65 years and older. Sex hormones have been implicated as having a critical role in the evolution of CVD, with the focus mainly on estrogens in women. Available data also indicate that low testosterone blood levels may be detrimental to cardiovascular function in women. At blood concentrations considered normal for premenopausal women, testosterone has favorable effects on blood vessel function (relaxation and contraction), much of which is determined by the endothelial cells that line the inside of blood vessels. Testosterone enhances endothelium-dependent and independent brachial artery vasodilation and has an acute systolic blood pressure-lowering effect in postmenopausal women. Advantageous effects of testosterone in animal models have been seen for myocardial function and cardiac electrical signaling. Human data are mainly limited to observational and mechanistic studies, which mostly demonstrate beneficial effects of testosterone on cardiovascular health. Few studies of testosterone use in women, with cardiovascular endpoints as primary outcomes, have been published.
Keyphrases
- replacement therapy
- postmenopausal women
- endothelial cells
- polycystic ovary syndrome
- blood pressure
- cardiovascular disease
- left ventricular
- pregnancy outcomes
- heart failure
- breast cancer risk
- smoking cessation
- bone mineral density
- cervical cancer screening
- machine learning
- systematic review
- big data
- physical activity
- artificial intelligence
- pregnant women
- randomized controlled trial
- intensive care unit
- single molecule
- deep learning
- high glucose
- cardiovascular events
- respiratory failure
- heart rate
- acute respiratory distress syndrome
- middle aged
- coronary artery disease
- hepatitis b virus